What is Acomplia?
*Acomplia (rimonabant) is the first in a new class of therapeutic agents called Cannabinoid-1 Receptor Blockers (CB1).
*Acomplia acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle.
*Acomplia is used complementary to diet and exercise to treat obese or overweight patients who suffer from Type 2 diabetes and abnormal levels of fat in the blood. |
 |
|
|  |
acomplia
alprazolam
ambien
ativan
carisoprodol
celexa
cialis
codeine
diazepam
diflucan
fioricet
glucophage
hoodia
levitra
lorazepam
meridia
nexium
paxil
phentermine
propecia
prozac
soma
tadalafil
tramadol
ultracet
ultram
valium
valtrex
viagra
xanax
xenical
zithromax
zoloft
zolpidem
zyban
|